Effect of 3,4,5,6-tetrahydroxyxanthone on erythrocyte deformability in apolipoprotein E-deficient mice

Journal of Asian Natural Products Research

Volumn 11, Issue 7, 2009, Pages 643-651

  Xiao, Hong Bo ^a   Lu, Xiang Yang ^a   Li, Yuan Jian ^b   Xu, Jian Ping ^a   Chao Tan, ^a   Sun, Zhi Liang ^a,c  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Hunan Veterinary Drug Engineering Technology Center   (China)

Author keywords

3,4,5,6 tetrahydroxyxanthone; Antioxidant enzymes; Apolipoprotein E deficient mice; Asymmetric dimethylarginine; Dimethylarginine dimethylaminohydrolase; Erythrocyte deformability

Indexed keywords

3,4,5,6 TETRAHYDROXYXANTHONE; APOLIPOPROTEIN E; CATALASE; DIMETHYLARGININASE; MALONALDEHYDE; N(G),N(G) DIMETHYLARGININE; POLYPHENOL DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE DEFORMABILITY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; TREATMENT DURATION;

ANIMALS; APOLIPOPROTEINS E; ARGININE; ATHEROSCLEROSIS; CATALASE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; SUPEROXIDE DISMUTASE; XANTHONES;

MUS;

EID: 70449627497     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020902953753     Document Type: Article

References (25)

1. A. Jendryczko and M. Pardela, Coret. Vasa. 34, 428 (1992).
2. M. Koter, M. Broncel, J. Chojnowska-Jezierska, K. Klikczynska, and I. Franiak, Eur. J. Clin. Pharmacol. 58, 501 (2002).
3. M. Bor-Kucukatay, R.B. Wenby, H.J. Meiselman, and O.K. Baskurt, Am. J. Physiol. Heart Circ. Physiol. 284, H1577 (2003).
4. R.H. Böger, Cardiovasc. Res. 59, 824 (2003).
5. Z.C. Yang, K. Xia, L. Wang, S.J. Jia, D. Li, Z. Zhang, S. Deng, X.H. Zhang, H.W. Deng, and Y.J. Li, Microvasc. Res. 73, 131 (2007).
6. H.B. Xiao, Z.C.Yang, S.J. Jia, N.S. Li, D.J. Jiang, X.H. Zhang, R. Guo, Z. Zhou, H.W. Deng, and Y.J. Li, Life Sci. 81, 1 (2007).
7. W. Mahabusarakam, J. Proudfoot, W. Taylor, and K. Croft, Free Radic. Res. 33, 643 (2000).
8. R. Gonda, T. Takeda, and T. Akiyama, Chem. Pharm. Bull. (Tokyo) 48, 1219 (2000).
9. T.L. Yang, M.F. Chen, B.L. Luo, J. Yu, J.L. Jiang, and Y.J. Li, Naunyn Schmiedebergs Arch. Pharmacol. 370, 79 (2004).
10. D.J. Jiang, G.Y. Hu, J.L. Jiang, H.L. Xiang, H.W. Deng, and Y.J. Li, Bioorg. Med. Chem. 11, 5171 (2003).
11. J. Hayashi, N. Ishida, H. Sato, Y. Hata, and T. Saito, J. Cardiovasc. Pharmacol. 27, 527 (1996).
12. M. Koter, I. Franiak, K. Strychalska, M. Broncel, and J. Chojnowska-Jezierska, Int. J. Biochem. Cell Biol. 36, 205 (2004).
13. R.A. Korbut, T. Adamek-Guzik, J. Madej, and R. Korbut, J. Physiol. Pharmacol. 53, 655 (2002).
14. S.J. Jia, D.J. Jiang, C.P. Hu, X.H. Zhang, H.W. Deng, and Y.J. Li, Vascul. Pharmacol. 44, 143 (2006).
15. E.S. Kang, T.B. Cates, D.N. Harper, T.M. Chiang, L.K. Myers, S.R. Acchiardo, and M. Kimoto, Free Radic. Res. 35, 693 (2001).
16. J.L. Jiang, H.Q. Zhu, Z. Chen,H.Y.Xu, and Y.J. Li, Int. J. Cardiol. 101, 153 (2005).
17. J. Murray-Rust, J. Leiper, M. McAlister, J. Phelan, S. Tilley, M.J. Santa, P. Vallance, and N. McDonald, Nat. Struct. Biol. 8, 679 (2001).
18. S.J. Lee and K.W. Lee, Biol. Pharm. Bull. 30, 1369 (2007).
19. G. Hacioglu, O. Yalcin, M. Bor-Kucukatay, G. Ozkaya, and O.K. Baskurt, Clin. Hemorheol. Microcirc. 26, 27 (2002).
20. M.R. Condon, J.E. Kim, E.A. Deitch, G.W. Machiedo, and Z. Spolarics, Am. J. Physiol. Heart Circ. Physiol. 284, H2177 (2003).
21. D.D. Kitts, Y.V. Yuan, and D.V. Godin, Can. J.Physiol.Pharmacol. 76, 202 (1998).
22. Y.V. Yuan, D.D. Kitts, and D.V. Godin, J. Nutr. 128, 1620 (1998).
23. Y.V. Yuan, D.D. Kitts, and D.V. Godin, Can. J. Physiol. Pharmacol. 74, 290 (1996).
24. B.M. Chen, L.W. Xia, and R.Q. Zhao, J. Chromatogr. B Biomed. Sci. Appl. 692, 467 (1997).
25. C.H. Chang, C.C. Lin, M. Hattori, and T. Namba, J. Ethnopharmacol. 44, 79 (1994).